STAT proteins in cancer: orchestration of metabolism

YJ Li, C Zhang, A Martincuks, A Herrmann… - Nature reviews Cancer, 2023 - nature.com
Reprogrammed metabolism is a hallmark of cancer. However, the metabolic dependency of
cancer, from tumour initiation through disease progression and therapy resistance, requires …

Targeting STAT3 in cancer immunotherapy

S Zou, Q Tong, B Liu, W Huang, Y Tian, X Fu - Molecular cancer, 2020 - Springer
As a point of convergence for numerous oncogenic signaling pathways, signal transducer
and activator of transcription 3 (STAT3) is central in regulating the anti-tumor immune …

Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma

J Feng, J Li, L Wu, Q Yu, J Ji, J Wu, W Dai… - Journal of Experimental & …, 2020 - Springer
Liver cancer has become the sixth most diagnosed cancer and the fourth leading cause of
cancer death worldwide. Hepatocellular carcinoma (HCC) is responsible for up to 75–85 …

Fibroblast pathology in inflammatory diseases

K Wei, HN Nguyen, MB Brenner - The Journal of clinical …, 2021 - Am Soc Clin Investig
Fibroblasts are important cells for the support of homeostatic tissue function. In inflammatory
diseases such as rheumatoid arthritis and inflammatory bowel disease, fibroblasts take on …

Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications

U Fearon, MM Hanlon, A Floudas… - Nature Reviews …, 2022 - nature.com
Activation of endothelium and immune cells is fundamental to the initiation of autoimmune
diseases such as rheumatoid arthritis (RA), and it results in trans-endothelial cell migration …

Glycolysis rate-limiting enzymes: novel potential regulators of rheumatoid arthritis pathogenesis

J Zuo, J Tang, M Lu, Z Zhou, Y Li, H Tian, E Liu… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a classic autoimmune disease characterized by uncontrolled
synovial proliferation, pannus formation, cartilage injury, and bone destruction. The specific …

A decade of JAK inhibitors: what have we learned and what may be the future?

C Liu, J Kieltyka, R Fleischmann… - Arthritis & …, 2021 - Wiley Online Library
The discovery of cytokines and their role in immune and inflammatory disease led to the
development of a plethora of targeted biologic therapies. Later, efforts to understand …

Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy

B Tang, J Zhu, Y Shi, Y Wang, X Zhang, B Chen… - Molecular Cancer, 2024 - Springer
Background The outcome of hepatocellular carcinoma (HCC) is limited by its complex
molecular characteristics and changeable tumor microenvironment (TME). Here we focused …

Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity

D Hermans, E Houben, P Baeten, H Slaets… - Acta …, 2022 - Springer
Oncostatin M (OSM) is an IL-6 family member which exerts neuroprotective and
remyelination-promoting effects after damage to the central nervous system (CNS) …

The clinical relevance of OSM in inflammatory diseases: a comprehensive review

CL Wolf, C Pruett, D Lighter, CL Jorcyk - Frontiers in Immunology, 2023 - frontiersin.org
Oncostatin M (OSM) is a pleiotropic cytokine involved in a variety of inflammatory responses
such as wound healing, liver regeneration, and bone remodeling. As a member of the …